Table 1 Patient clinical information and pathology data
|  | LUAD (N = 515) | LUSC (N = 502) | Total (N = 1017) |
|---|---|---|---|
Stage | |||
N/A | 8 (1.6%) | 5 (1.0%) | 13 (1.3%) |
Stage I | 275 (53.4%) | 244 (48.6%) | 519 (51.0%) |
Stage II | 122 (23.7%) | 162 (32.3%) | 284 (27.9%) |
Stage III | 84 (16.3%) | 84 (16.7%) | 168 (16.5%) |
Stage IV | 26 (5.0%) | 7 (1.4%) | 33 (3.2%) |
Gender | |||
N/A | 0 (0.0%) | 1 (0.2%) | 1 (0.1%) |
FEMALE | 277 (53.8%) | 130 (25.9%) | 407 (40.0%) |
MALE | 238 (46.2%) | 371 (73.9%) | 609 (59.9%) |
Age | |||
Mean (SD) | 62.955 (15.722) | 65.865 (12.670) | 64.391 (14.364) |
Range | 0.000–88.000 | 0.000–90.000 | 0.000–90.000 |
TP53 | |||
N/A | 17 (3.3%) | 21 (4.2%) | 38 (3.7%) |
Unaltered | 228 (44.3%) | 65 (12.9%) | 293 (28.8%) |
Altered | 270 (52.4%) | 416 (82.9%) | 686 (67.5%) |
Mutation_Count | |||
N/A | 17 (3.3%) | 21 (4.2%) | 38 (3.7%) |
< 150 | 218 (42.3%) | 110 (21.9%) | 328 (32.3%) |
> 300 | 152 (29.5%) | 123 (24.5%) | 275 (27.0%) |
150–300 | 128 (24.9%) | 248 (49.4%) | 376 (37.0%) |
Tobacco_Smoking_History | |||
N/A | 14 (2.7%) | 13 (2.6%) | 27 (2.7%) |
1 | 75 (14.6%) | 18 (3.6%) | 93 (9.1%) |
2 | 119 (23.1%) | 133 (26.5%) | 252 (24.8%) |
3 | 135 (26.2%) | 83 (16.5%) | 218 (21.4%) |
4 | 168 (32.6%) | 250 (49.8%) | 418 (41.1%) |
5 | 4 (0.8%) | 5 (1.0%) | 9 (0.9%) |